A.G.Barr PLC (BAG)
London Exchange · UK · prices in GBX · close of 21 Oct 2026
Key indicators
| Last close | GBX 577.00 |
|---|---|
| 52-week range | 534.33 – 693.33 |
| Return, 1 month / 3 months | −3.8% / −9.2% |
| Return, 1 year / 3 years | −13.6% / +22.8% |
| Trend | Below its 200-day average |
| RSI (14) | 54 |
| Volatility (1 year) | 21.2% |
| Worst drawdown (1 year) | -21.6% |
| Average daily value traded | 164.87M GBX |
| Dividend yield | 0.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
A.G. Barr is a Scottish soft drinks company based in Cumbernauld. It makes and sells carbonated and still beverages, including its flagship orange drink Irn-Bru, along with other fizzy drinks, fruit juices and mixers. Its customers are grocery retailers, convenience stores, wholesalers and food service outlets, mainly across the United Kingdom, where its brands are familiar to shoppers. The business also exports some products to overseas markets.
The shares are listed on the London Exchange in UK under the code BAG, and the price on this page is in pence sterling (GBX). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
A.G.Barr PLC (BAG) trades on the London Exchange in UK. It last closed at GBX 577.00 on 21 October 2026.
Its price-based Market X-Ray is 52 out of 100 (a fair price profile), ranking 1,930 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 13.6% and over the last three months it fell 9.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 37 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -6.5% | ||
| From 52-week high | -15.9% | ||
| Momentum | 30 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -9.2% | ||
| 6-month return | -6.9% | ||
| 12-month return, skipping the last month | -10.2% | ||
| Stability (higher is calmer) | 76 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 21.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -21.6% | ||
| Liquidity | 91 · Strong | Trades actively. | |
| Average daily value traded | 164.87M GBX | ||
| Zero-volume days | 0.0% | ||
| Income | 29 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.0% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Income: Dividend is small or irregular.
Returns
| 1 week | +3.0% |
|---|---|
| 1 month | −3.8% |
| 3 months | −9.2% |
| 6 months | −6.9% |
| 1 year | −13.6% |
| 3 years | +22.8% |
| 5 years | +28.8% |
Signals
| 50-day / 200-day average | 582.74 / 617.29 |
|---|---|
| Golden / death cross (60 days) | Death, 41 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 14.67 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 8 Oct 2026 | GBP 0.0382 |
| 7 May 2026 | GBP 0.1527 |
| 9 Oct 2025 | GBP 0.0344 |
| 8 May 2025 | GBP 0.1376 |
| 3 Oct 2024 | GBP 0.0310 |
| 9 May 2024 | GBP 0.1240 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.